Janice Elaine Bennett, ARNP

Janice Bennett practices at Moffitt Cancer Hospital in Tampa, Florida, part of Moffitt Cancer Center.

Janice Bennett's NPI, 1447642707, was assigned on February 24, 2015. Janice Bennett holds Florida license ARNP 9323649.

Janice Bennett's primary practice is Moffitt Cancer Hospital, at 12902 Magnolia Dr, Tampa, FL 33612. Janice Bennett also practices at H. Lee Moffitt Cancer Center and Research Institute Hospital, Inc., 10920 McKinley Dr, Tampa, FL 33612.

Janice Bennett's primary practice is Moffitt Cancer Hospital in Tampa, Florida, part of Moffitt Cancer Center. Janice Bennett is also affiliated with AdventHealth Tampa. The medical group on file is Moffitt Cancer Center. Dmand AI also links Janice Bennett to 1 more breast imaging center, 1 group practice or clinic and 1 hospital outpatient department, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Janice Bennett practices, 5 sites in all. Vendor and product names are available with a free account.

Nurse practitioner is Janice Bennett's primary specialty in the NPI Registry, under taxonomy code 363L00000X. Janice Bennett is licensed in Florida.

Dmand AI lists contact dermatitis and rash among the conditions Janice Bennett treats.

CMS data shows 460 Medicare services from Janice Bennett across 4 procedure codes in 2024, for 221 Medicare patients. Medicare paid $27,142 for them.

CMS counts 221 Medicare patients who saw Janice Bennett in 2024. The largest group is 65 to 74, with 112 patients. 75% of them have high cholesterol, and 73% have high blood pressure. 6% are also on Medicaid. Their average risk score is 2.15, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Janice Bennett's median patient age at 71, with 41% women.

In 2024, Janice Bennett wrote 214 Medicare Part D claims for 59 patients. 81% of them were for generic drugs. CMS names the drug for 87 of them, across 6 drugs with 11 or more claims each, at $119,657 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Janice Bennett for performance year 2024, reported as part of a group. Janice Bennett accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Janice Bennett as offering telehealth.

CMS Open Payments shows 2 general payments to Janice Bennett from 2 drug and device companies from 2024 to 2025. Consulting fees make up the largest share, 92% of the total. Kyowa Kirin, Inc. paid the most, $700.